These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38797178)
1. Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance. Laxminarayan R; Impalli I; Rangarajan R; Cohn J; Ramjeet K; Trainor BW; Strathdee S; Sumpradit N; Berman D; Wertheim H; Outterson K; Srikantiah P; Theuretzbacher U Lancet; 2024 Jun; 403(10443):2534-2550. PubMed ID: 38797178 [TBL] [Abstract][Full Text] [Related]
2. To Push or To Pull? In a Post-COVID World, Supporting and Incentivizing Antimicrobial Drug Development Must Become a Governmental Priority. Cama J; Leszczynski R; Tang PK; Khalid A; Lok V; Dowson CG; Ebata A ACS Infect Dis; 2021 Aug; 7(8):2029-2042. PubMed ID: 33606496 [TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005. Finch R; Hunter PA J Antimicrob Chemother; 2006 Sep; 58 Suppl 1():i3-i22. PubMed ID: 17003063 [TBL] [Abstract][Full Text] [Related]
4. Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach. Mendelson M; Lewnard JA; Sharland M; Cook A; Pouwels KB; Alimi Y; Mpundu M; Wesangula E; Weese JS; Røttingen JA; Laxminarayan R Lancet; 2024 Jun; 403(10443):2551-2564. PubMed ID: 38797179 [TBL] [Abstract][Full Text] [Related]
5. A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future. Ohashi T; Nagashima M; Kawai N; Ohmagari N; Tateda K Expert Rev Anti Infect Ther; 2022 Dec; 20(12):1603-1614. PubMed ID: 36368311 [TBL] [Abstract][Full Text] [Related]
6. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. Lucien MAB; Canarie MF; Kilgore PE; Jean-Denis G; Fénélon N; Pierre M; Cerpa M; Joseph GA; Maki G; Zervos MJ; Dely P; Boncy J; Sati H; Rio AD; Ramon-Pardo P Int J Infect Dis; 2021 Mar; 104():250-254. PubMed ID: 33434666 [TBL] [Abstract][Full Text] [Related]
7. Available evidence and potential for vaccines for reduction in antibiotic prescriptions. Gabutti G Hum Vaccin Immunother; 2022 Dec; 18(7):2151291. PubMed ID: 36469620 [TBL] [Abstract][Full Text] [Related]
8. The interface between COVID-19 and bacterial healthcare-associated infections. O'Toole RF Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586 [TBL] [Abstract][Full Text] [Related]
9. Innovation in Antimicrobial Resistance: The CARB-X Perspective. Alm RA; Gallant K ACS Infect Dis; 2020 Jun; 6(6):1317-1322. PubMed ID: 32202756 [TBL] [Abstract][Full Text] [Related]
10. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Antimicrobial Resistance Collaborators Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702 [TBL] [Abstract][Full Text] [Related]
13. Strategies to improve antibiotic access and a way forward for lower middle-income countries. Wasan H; Reeta KH; Gupta YK J Antimicrob Chemother; 2024 Jan; 79(1):1-10. PubMed ID: 38008421 [TBL] [Abstract][Full Text] [Related]
14. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs. Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275 [TBL] [Abstract][Full Text] [Related]
15. The potential of 4D's approach in curbing antimicrobial resistance among bacterial pathogens. Thakur L; Singh S; Singh R; Kumar A; Angrup A; Kumar N Expert Rev Anti Infect Ther; 2022 Nov; 20(11):1401-1412. PubMed ID: 36098225 [TBL] [Abstract][Full Text] [Related]
16. A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution. Piddock LJV; Paccaud JP; O'Brien S; Childs M; Malpani R; Balasegaram M Clin Infect Dis; 2022 May; 74(10):1866-1871. PubMed ID: 34618892 [TBL] [Abstract][Full Text] [Related]